MAM
Shriram Sanjeevi moves on from Levista Coffee
NEW DELHI: Levista Coffee vice president Shriram Sanjeevi has moved on after a 16-month-long stint at the brand.
According to reports, Sanjeevi announced the news in a personal message to industry colleagues. "I have stepped down from Levista on 3 April 2021. Levista Coffee is poised for a huge leap of growth this new financial year, and it’s all in your hands to support this budding baby brand and help it to scale great heights. I will cherish every moment that I’ve spent in this company all my life,” he wrote.
At Levista, he led the sales and marketing division, branding, supply chain management and overall business strategy.
An IIM-Bangalore alumnus, Sanjeevi has worked with marquee companies such as RPG Retail, The Future Group, Café Coffee Day and Royal Enfield (Eicher Motors). In 2006, he joined the start-up team responsible for the opening of Kempegowda International Airport in Bengaluru, which also happened to be India’s first private greenfield airport.
In his subsequent roles, he helped set up 140 outlets for Café Coffee Day across India and had a two-year spell with Royal Enfield Motorcycles, where he was responsible for expanding the company’s dealership network.
During his close to 25 years in the retail industry, Sanjeevi has been conferred several awards that include Top 100 Retail Minds by World Federation of Marketing in 2018, and Top 50 Retail Professionals of India by Asia Retail Congress in 2014.
Homegrown coffee brand Levista is currently present across Tamil Nadu, Karnataka, Puducherry, Andhra Pradesh and Telangana.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
